The Shineco Inc (NASDAQ: SISI) stock price rallied 52.2% despite the lack of recent news releases from the Chinese company. The lack of news means we can attribute today’s rally to positive investor sentiment and buying pressure.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Given that Shineco is a microcap stock with a market capitalisation of just over $3 million, we do not need a lot of buying to trigger a rally in its share price. However, stock market data indicates that over 15.89 million SISI shares had changed hands at writing.Â
Top Broker Recommendation
- BlackBull 26,000+ Shares, Options, ETFs, Bonds, and other underlying assets – Read our Review
- Admiral Markets More than 4500 stocks & over 200 ETFs available to invest in – Read our Review
- Hargreaves Lansdown The company's website is easily understandable and accessible to a wide range of customers – Read our Review
- eToro Wide range of instruments available to trade – Read our Review
- IG Top-tier regulation – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
The large number of shares changing hands indicates that Shineco stock is extremely popular among investors today. Let’s look at its past releases to see if we can find a reason why the investors who are buying SISI stock are so bullish on the stock.
Shineco’s last major announcement was on July 10, 2023, when it revealed that Changzhou Biowin Pharmaceutical, a majority-owned subsidiary of the Company, received marketing and distribution approval for its Cardiac 5-Minute Test from the Jiangsu Bureau of the National Medical Products Administration, NMPA, which is China's regulatory equivalent of the U.S. Food and Drug Administration (FDA).
At the time, Dr. Marvin Liu, CEO of Biowin, said: “We are very glad to have received marketing approval for our Cardiac 5-Minute Test from the NMPA. This is a significant milestone for our business, and we believe that the diagnostic test will achieve high acceptance in the Chinese market. As the inventor of the technology for the Cardiac 5-Minute Test, we are pleased that its fast detection marks a significant technical breakthrough that sets our diagnostic medical product apart from other products on the market. It provides a new and highly valuable approach to conducting cardiac marker tests within 5 minutes, which we believe will save lives in China and throughout the world.”
Another announcement from Shineco was that its wholly owned subsidiary, Shineco Life Science Research Co., signed a joint venture cooperation agreement with Yangzhou Kangling Medical to establish a joint venture company, Shangkang Life Science and Technology.
Still, the two announcements are from a long time ago. Hence, we cannot attribute today’s price rally to the same.
Shineco stock price.
The Shineco stock price rallied 52.22% to trade at $0.22, rising from Monday’s closing price of $0.1429.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.